Accuracy of the automated assessment of left ventricular function with gated perfusion SPECT in the presence of perfusion defects and left ventricular dysfunction: Correlation with equilibrium radionuclide ventriculography and echocardiography

被引:55
作者
Chua, T
Yin, LC
Thiang, TH
Choo, TB
Ping, DZ
Leng, LY
机构
[1] Natl Heart Ctr, Dept Cardiol, Singapore 168752, Singapore
[2] Minist Hlth, Med Statistician Clin Trials & Epidemiol Res Unit, Singapore, Singapore
基金
英国医学研究理事会;
关键词
automated gated SPECT; left ventricular function; equilibrium radionuclide ventriculography; echocardiography; perfusion defects;
D O I
10.1067/mnc.2000.105279
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Gated single photon emission computed tomography (SPECT) with automated methods allows the quantitative assessment of left ventricular function and perfusion; however, its accuracy must be defined for patients with large earlier infarctions and severe rest perfusion defects, in whom the estimation of endocardial and epicardial borders might be more difficult, even with automated edge-detection techniques. Methods and Results, We prospectively compared the automated measurements of left ventricular ejection fraction (LVEF) and volumes from rest-injected gated Technetium 99m (Tc-99m) perfusion SPECT with equilibrium radionuclide angiocardiography (ERNA) in 62 patients and the assessment of regional function,vith echocardiography in 22 patients. Forty-six patients had an earlier myocardial infarction (mean defect size, 34% of left ventricle; SD, 12.7%; range, 8% to 56%); 27 patients had large defects (greater than or equal to 20% of left ventricle; LVEF range, 8% to 75%), LVEF, as determined with Cedars-Sinai software (quantitative gated SPECT), correlated well with ERNA (r = 0.941; y = 1,003x + 1.15; P < .0001; SE of the estimate = 6.3%; mean difference -1.3% for LVEF) in the entire study population and in the subgroups of patients with an earlier infarction, severe defects, and large infarctions (greater than or equal to 20% of the left ventricle), A correlation existed between gated SPECT and ERNA volumes (r = 0.882, y = 1.040x - 14.7, P < .0001 for end-diastolic volume; r = 0.954, y = 1.147x - 13.9, P < .0001 for end-systolic volumes with the count-ratio technique), but with wider limits of agreement. The exact segmental score agreement between gated SPECT and echocardiography for regional function was 79.8% (281 of 352, kappa = 0.682), Conclusions, Automated gated SPECT provides an accurate assessment of ejection fraction and regional function, even in the presence of an earlier myocardial infarction with large perfusion defects and significant left ventricular dysfunction.
引用
收藏
页码:301 / 311
页数:11
相关论文
共 32 条
[1]  
*AM SOC ECH COMM S, 1989, J AM SOC ECHOCARDIOG, V2, P358
[2]   Regional myocardial motion and thickening assessed at rest by ECG-gated Tc-99m-MIBI emission tomography and by magnetic resonance imaging [J].
Anagnostopoulos, C ;
Gunning, MG ;
Pennell, DJ ;
Laney, R ;
Proukakis, H ;
Underwood, SR .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (08) :909-916
[3]   Comparison of post-stress ejection fraction and relative left ventricular volumes by automatic analysis of gated myocardial perfusion single-photon emission computed tomography acquired in the supine and prone positions [J].
Berman, D ;
Germano, G ;
Lewin, H ;
Kang, XP ;
Kavanagh, PB ;
Tapnio, P ;
Harris, M ;
Friedman, J .
JOURNAL OF NUCLEAR CARDIOLOGY, 1998, 5 (01) :40-47
[4]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[5]   GATED TC-99M SESTAMIBI FOR SIMULTANEOUS ASSESSMENT OF STRESS MYOCARDIAL PERFUSION, POSTEXERCISE REGIONAL VENTRICULAR-FUNCTION AND MYOCARDIAL VIABILITY - CORRELATION WITH ECHOCARDIOGRAPHY AND REST TL-201 SCINTIGRAPHY [J].
CHUA, T ;
KIAT, H ;
GERMANO, G ;
MAURER, G ;
VANTRAIN, K ;
FRIEDMAN, J ;
BERMAN, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (05) :1107-1114
[6]   A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].
COHN, JN ;
JOHNSON, G ;
ZIESCHE, S ;
COBB, F ;
FRANCIS, G ;
TRISTANI, F ;
SMITH, R ;
DUNKMAN, WB ;
LOEB, H ;
WONG, ML ;
BHAT, G ;
GOLDMAN, S ;
FLETCHER, RD ;
DOHERTY, J ;
HUGHES, CV ;
CARSON, P ;
CINTRON, G ;
SHABETAI, R ;
HAAKENSON, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310
[7]  
DEPUEY E, 1995, J NUCL MED, V36, P952
[8]  
DEPUEY EG, 1993, J NUCL MED, V34, P1871
[9]  
Faber TL, 1999, J NUCL MED, V40, P650
[10]  
FABER TL, 1991, J NUCL MED, V32, P2311